Prescribing for Dry Eye Disease - Takeaways - MDSpire

Prescribing for Dry Eye Disease

The Tear Film and Ocular Surface Society (TFOS) Dry Eye Workshop (DEWS) III report, which was recently released, includes an updated prescribing algorithm based on DED etiology or pathogenic drivers.

  • By

  • LISA HORNICK, OD, MBA, FAAO

  • July 1, 2025

  • 7 min

Share

  • 1

    The TFOS DEWS III report categorizes dry eye disease (DED) into three main drivers: tear film deficiencies, eyelid abnormalities, and ocular surface abnormalities.

  • 2

    A targeted treatment approach based on the main cause of DED is recommended, utilizing therapies like artificial tears, lid hygiene, and ocular surface regenerators.

  • 3

    Meibomian gland dysfunction (MGD) is a primary cause of evaporative DED, requiring evidence-based therapies such as vitamin D3 and in-office tear stimulation.

  • 4

    Anatomic misalignment and neural dysfunction can contribute to DED, with potential surgical interventions and treatments like moisture chamber goggles for severe cases.

  • 5

    Lifestyle factors, including sleep, diet, and mental health, significantly impact DED, necessitating patient education on these aspects for effective management.

Original Source(s)

Prescribing for Dry Eye Disease

  • by LISA HORNICK, OD, MBA, FAAO

  • July 1, 2025

Related Content

Music May Ease Anxiety in Eye Clinics

Background music and multimedia exposure were associated with lower patient-reported anxiety in a quasi-experimental ophthalmology clinic study that used existing clinic audiovisual infrastructure at no additional cost.

Driving Progress in Dry Eye Care

WCO and Alcon renew global dry eEye education partnership

  • February 5, 2026

  • 3 min
The Relationship of Tear Film Instability and Higher-Order Aberrations to Refractive Variability

Jade Coats, OD, discusses the effects of higher-order abberations on refractions and what to do about them.